Future Generali India Life Nears Breakeven; FY25 Individual New Business Premium Up 19% to Rs 476 Cr

Mumbai (Maharashtra) [India], June 9: Future Generali India Life Insurance (FGILI) today announced its business and financial performance for FY 2024–25. The Company’s total new business premium increased by 96% to ₹1,192 crore in FY25, up from ₹609 crore in FY24. While individual new business premium rose by 19% to ₹476 crore in FY25 from ₹398 crore in FY24, group new business premium increased by 240% to ₹716 crore in FY25 from ₹211 crore in FY24.

The gross written premium of the Company also marked an increase of 39% to ₹2,511 crore in FY25, up from ₹1,811 crore in FY24. The Company is nearing breakeven, reporting a loss of ₹6.4 crore only in FY25—down by 94% from ₹113.9 crore in FY24.

Moreover, the Company reinforced its commitment to policyholder satisfaction and financial security, with the claim settlement ratio for individual business rising to 98.08% in FY25, up from 96.08% in FY24. Similarly, the claim settlement ratio for group business increased to 99.78% in FY25 from 99.18% in FY24.

Renewal premiums also recorded a 10% year-on-year increase, reaching ₹1,318 crore in FY25 from ₹1,201 crore in FY24, reflecting the Company’s strong policyholder retention and sustained engagement.

The Company’s Assets Under Management (AUM) rose to ₹8,784 crore in FY25 as compared to ₹7958 crore in the previous fiscal year. This growth in AUM demonstrates the Company’s strong fund management capabilities and continued trust from policyholders.

The flagship Equity ULIP Fund—Future Midcap Fund has delivered over 33% CAGR returns over the last five years and holds a 4-star rating from Morningstar. Since its inception in November 2018, the fund has outperformed the benchmark by 2.9%, demonstrating consistent performance and strong returns.

The total sum assured in effect also increased by 9%, amounting to ₹1,61,595 crore, compared to FY24 at ₹1,47,781 crore. The Company has also expanded its distribution footprint by introducing new products, increasing operational units, and strengthening partnerships, ensuring broader market reach and enhanced accessibility for customers across diverse segments.

While commenting on the business achievements, Mr. Alok Rungta, MD & CEO at Future Generali India Life Insurance said “We are proud of the remarkable business growth achieved by Future Generali India Life Insurance Co. Ltd in FY25. With a customer-first mindset and strategic investments in technology and talent, we continue to create value for customers and stakeholders. This remarkable performance is a testament to our dedication to delivering transparent, efficient, and customer-first financial solutions, reinforcing our position as a trusted partner in securing financial futures. Building on this success, we remain focused on innovation, expanding product offerings, and deepening customer engagement to continue driving excellence in the insurance sector. We remain committed to simplifying life insurance for our customers and making it more accessible for everyone, while continuing to deliver value across our distribution channels.”

ABOUT FUTURE GENERALI INDIA LIFE INSURANCE

Future Generali India Life Insurance Company Ltd. is headquartered in Mumbai and was established in 2006. The Company has a presence in 1300+ owned and partnered locations in India and offers total insurance solutions across both the individual and group fronts. Generali is the largest shareholder in Future Generali India Life Insurance with a stake of 73.99% in the Company. Generali brings in 190+ years of insurance expertise as well as its global network’s best practices, capabilities, and resources, driving sustainable and profitable growth for communities, clients, employees, and shareholders. Established in 1831, Generali is present in over 50 countries in the world, with 82 thousand employees serving 68 million customers globally.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Agartala Business Dr. Saikat Kar innovation Neurotech Startup Science

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More
Business Harsheep Hortico Limited

Harshdeep Hortico Reports Strong H1 FY26 with Net Profit of INR 5.7 crore

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26. Key H1 FY25 Financial Highlights Key Financial Highlights (Consolidated) – H1 FY2025-26 Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in […]

Read More